Multilamellar liposomes of triamcinolone acetonide: Preparation, stability, and characterization Multilamellar liposomes of triamcinolone acetonide Clares B. et al.

Journal of Liposome Research

Volumn 19, Issue 3, 2009, Pages 197-206

  Clares, B ^a   Gallardo, V ^a   Medina, M M ^a   Ruiz, M A ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

L posomes; Stability; Triamcinolone acetonide; Vitamin

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; LIPOSOME; TRIAMCINOLONE ACETONIDE;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; LIPID VESICLE; LIPOSOMAL DELIVERY; PRIORITY JOURNAL; ROOM TEMPERATURE;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CHOLESTEROL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; LIPOSOMES; MATERIALS TESTING; PARTICLE SIZE; TEMPERATURE; TRIAMCINOLONE ACETONIDE;

EID: 70350689701     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100902736571     Document Type: Article

References (32)

1. Bangham AD, Hill MW, Miller NGA. (1974). Preparation and use of liposomes as models of biological membranes. In: Methods in Membrane Biology (pp 1-68). New York: Korn E.D. Plenum Press.
2. Cevc G, Blume G, Schatzlein A. (1997). Transfersomers mediated. Transepidermal delivery improves the regio-specificity and biological-activity of corticosteroids in vivo. J Contr Rel 45:211-226.
3. Chiu SJ, Liu S, Perrotti D, Marcucci G, Lee RJ. (2006). Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferring receptor-targeted liposomes. J Contr Rel 112:199-207.
4. Chou HH, Wang KL, Chen CA, Wei LH, Hsieh CY, Yang YC, et al. (2006). Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up. Gynecol Oncol 101:423-428.
5. Clares B, Medina MM. (2007). Liposomal triamcinolone acetonide: Influence of composition in performance and stability. Ars Pharm 48:19-29.
6. Doba T, Burton GW, Ingold KU. (1985). Antioxidant and coantioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochim Biophys Acta 835:298-303.
7. Dufourc J. (1985). Physical Chemistry of Phospholipids. In: The liposomes, therapeutic applications. Paris: Technique & Documentation, pp 1-10.
8. Fesq H, Glöckner A, Abeck D, Ring J, Lehmann J, Rother M, et al. (2003). Improved risk-benefit ratio for a triamcinolone acetonide Transfersome® formulation in comparison to a commercial triamcinolone acetonide formulation. Biochim Biophysica Acta Biomembr 1614:156-164.
9. Frenkel V, Etherington A, Greene M, Quijano J, Xie J, Hunter F, et al. (2006). Delivey of liposomal doxorubicin (Doxil) in a breast cancer tumor model: Investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad Radiol 13:469-479.
10. Grit M, Crommelin DJA. (1993). Chemical stability of liposomes: Implications for their physical stability. Chem Phys Lipids 64:3-18.
11. Guzman M, Selles E, Aberturas MR. (1989). Effect of human plasma on the stability of large multilamellar liposomes with digitoxin. Drug Dev. Ind. Pharm. 11:1759-1770. (Pubitemid 19194667)
12. Harsanyi BB, Hilchie JC, Mezei M. (1986). Liposomes as drug carriers of oral ulcers. J Dent Res 65:1.113-1.141.
13. Hayat MA. (1989). Principles and Techniques of Electron Microscopy. Biological Applications, 3rd ed (pp 251-253). Macmillan Press.
14. Hui YN, Liang HC, Cai YS, Kirchhof B, Heimann K. (1993). Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Graefe's Arch Clin Exp Ophthalmol 231:109-114.
15. Hunt CA, Tsang S. (1981). α-tocpherol retards autoxidation and prolongs the shelf life of liposomes. Int J Pharm 8:101-110.
16. Joshi MR, Misra A. (2001). Liposomal budesonide for dry powder inhaler: Preparation and stabilization. Pharm Sci Tech 2:E25.
17. Korting HC, Zienicki H, Schaefer-Korting M, Braun-Falco O. (1990). Liposome encapsulation improves efficacy of betamethasone diproprionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 39:349-351.
18. Law SL, Huang KJ. (2001). Preparation of desmopressin-containing liposomes for intranasal delivery. J Contr Rel 70:375-382.
19. McMullen JN, Newton DW, Becker CH. (1984). Pectin-gelatin complex cohacervates. Effect of microemcapsulates sulfamerazine on size, morphology, recovery, and straction of water dispersible microglobules. J Pharm Sci 73:1799-1803.
20. Mezei M, Gulasekharam V. (1980). Liposomes, a selective drug delivery sistem for the topical route of administration. I. Lotion dosage form. Life Sci 26:1473-1477.
21. Mezei, M. (1985). Liposomes as a Skin Drug Delivery Systems. D. D. Breimer A. In: Topics in Pharmaceutical Sciences. pp 345-358. Amsterdam P. Speiser, Eds., Elsevier Sci. Pub.
22. Nicolazzo JA, Reed BL, Finnin BC. (2005). Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Contr Rel 105:240-248.
23. Pasarassi T, Giusti AM, Raimondi M, Ravagnan G, Sapora O, Gratton E. (1995). Cholesterol protects the phospholipid bilayer from oxidative damage. Free Radic Biol Med 19:511-516.
24. Puisieux F, Poly PA. (1985). Technological Problems for the use of liposomes as delivery vehicles for active ingredients, encapsulation, sterilization, preservation. In: Les liposomes, applications thérapeutiques. Paris: Technique & Documentation, pp 13-113.
25. Samuni AM, Lipman A, Barenholz Y. (2000). Damage to liposomal lipids: Protection by antioxidants and cholesterol-mediated dehydration. Chem Phys Lipids 105:121-134.
26. Shaw IH, Knight CG, Dingle JT. (1976). Liposomal retention of a modified anti-inflammatory steroid. J Biochim 158:473-476.
27. Soto-Arriaza MA, Sotomayor CP, Lissi EA. (2008). Relationship between lipid peroxidation and rigidity in L-α-phosphatidylcholine-DPPC vesicles. J Coll Interf Sci 23:70-74.
28. Vasson MP, Colombat A, Madelmont JC, Moreau MF, Godeneche D, Delattre J. (1981). Comparative study of encapsulation in liposomes of Nitros-urea. First European Congress of Pharmacokinetics and biopharmacy. Vol.I. Clermont-Ferrand, pp 381.
29. Vemuri S, Rhodes CT. (1995). Encapsulation of a water-soluble drug in a liposome preparation: Removal of free drug by washing. Drug Dev Ind Pharm 21:1329-1338.
30. Virtanen JA, Ruinala M, Vauhkonen M, Somerharju P. (1995). Lateral organization of liquid-crystalline colesterol-dimyristoylphosphatidylcholine bilayers. Evidence for domains with hexagonal and centered rectangular cholesterol superlattices. Biochemistry 34:11568-11581.
31. Yamabe K, Yoshinori K, Hiraku O. (2003). Potentially of double liposomes containing salmon calcitonin as an oral dosage form. J Contr Rel 89:429-436.
32. Zhang C, Tang N, Liu X, Liang W, Xu W, Torchilin VP. (2006). siRNAcontaining liposomes modified with polyarginine silence the targeted gene. J Contr Rel 112:229-239.